Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02253030

OCT Angiography in Wet AMD

Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration

Status
Recruiting
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
50 Years – 100 Years
Healthy volunteers
Accepted

Summary

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD) 2. evaluate patients undergoing treatment for wet AMD 3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.

Conditions

Interventions

TypeNameDescription
DEVICEOptical Coherence Tomography

Timeline

Start date
2014-09-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2014-10-01
Last updated
2024-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02253030. Inclusion in this directory is not an endorsement.